|
advertisement
|
|
TOP STORIES
Updates on COVID-19 vaccine candidates, FDA policies, company partnerships, and more.
/ read more /
|
| |
|
The companies have entered into a collaboration agreement to develop and commercialize three of Genmab's early-stage investigational bispecific antibody product candidates.
/ read more /
|
|
| |
ADVERTISEMENT
Featured Resources from BioPharm International
View our online resource center, sponsored by GE Healthcare, to explore a case study and articles on gaining and retaining skilled labor, modular bioprocessing, the good and bad of biosilimiars, and more.
Learn More »  |
| |
|
SubscribeSubscribers can enjoy each full issue of BioPharm International in print, or via BioPharm apps.
subscription offers
|
|
|
Industry News
Will efforts to limit all returns on investment drive biopharma companies away from developing much-needed interventions for COVID-19.
/ read more /
The agency published guidance to clarify its enforcement of distribution of drug samples for drug marketing during COVID-19.
/ read more /
MORE INDUSTRY NEWS
|
| |
ADVERTISEMENT
Innovative Solutions for Protein Analysis and Purification: mAbs and Oligos
An online resource to discover an innovative solution for protein analysis and purification. This site includes useful webcasts, application notes, and more.
Discover now » |
| |
|
|
Biopharma News
The Biomedical Catalyst has been relaunched, meaning that innovative biotech companies will have the opportunity to access a share of £30 million (US$38 million) in grant funding.
/ read more /
Oxford Biomedica, has signed a collaboration agreement with the not-for-profit organization, the Vaccines Manufacturing and Innovation Centre, to provide the UK with its first strategic vaccine development and advanced manufacturing capability.
/ read more /
More Biopharma News
|
| |
|
Supplier News
The companies have entered into a development and manufacturing agreement for Anthos Therapeutics’ abelacimab for treating thrombotic disorders.
/ read more /
|
|
Catalent will use its GPEx cell line development technology to create a cell line expressing the recombinant VLP at its Madison, WI facility.
/ read more /
More Supplier News
|
|
Regulatory News
The agency has added a COVID-19 innovation resource page and an education resources page to its website.
/ read more /
|
The 120-day pilot program was set up to help reduce the availability of unapproved opioids illegally offered for sale online.
/ read more /
More Regulatory News
|
|
FEATURED TOPICS |
|
UPSTREAM PROCESSING
Therapies for early and late treatment and passive immunization of COVID-19 are needed and can be developed using antibodies from recovered patients.
/ read more /
|
|
|
|
|
|
PEER-REVIEWED RESEARCH
Advanced data analytics, including statistical modeling and machine learning technique, can enable more efficient and reliable bioprocesses.
/ read more /
|
|
|
|
ANALYTICAL METHODS
Bioanalytical studies are an important aspect of biologic drug development that may necessitate partnering with bioanalysis experts.
/ read more /
|
|
|
eBook
|
The Pharmacopoeia Compliance Series features a description of ways biopharma companies can participate in monograph development, a case study of a practical approach to pharmacopoeial compliance, and a summary of this 12-part series.
|
|
|
|
| |
